Background: Dementia and its related types such as Alzheimer's disease, vascular dementia
and mixed dementia belong to brain associated diseases, resulting in long-term progressive …

Alzheimer's Disease (AD) is one of the most common forms of dementia affecting over 46
million people, according to AD International. Over the past few decades, there has been …

Effective therapy for Alzheimer's disease is a major challenge in the pharmaceutical
sciences. There are six FDA approved drugs (eg, donepezil, memantine) that show some …

Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …

The administration of promising medications for the treatment of neurodegenerative
disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's …

Introduction: Brain is supposed to be the most complicated part of the body which is very far
from the reach of drug moieties. The drug entry in to the brain region depends upon various …

Alzheimer's disease is the most serious neurodegenerative disorder characterized by
cognitive and memorial defects alongside deterioration in behavioral, thinking and social …

Donepezil hydrochloride (DPL) and Embelin (EMB) loaded Nanostructured Lipid Carriers
(NLCs) have been developed and optimized to achieve optimal drug loading, safer nasal …

Alzheimer's disease (AD) is a neurodegenerative disease with high prevalence in the
rapidly growing elderly population in the developing world. The currently FDA approved …

One of the most common forms of neurodegenerative disorders, Alzheimer's disease poses
a great threat to patients all over the globe with about 5.7 million cases estimated by the …